PD-L1 Antikörper (AA 39-191)
Kurzübersicht für PD-L1 Antikörper (AA 39-191) (ABIN6936651)
Target
Alle PD-L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 39-191
-
Spezifität
- PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
-
Kreuzreaktivität (Details)
- Human.
-
Aufreinigung
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogen
- Recombinant fragment of human CD274 protein (around aa39-191) (exact sequence is proprietary)
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Known_Application: ELISA (For coating, order antibody without BSA), ,Optimal dilution for a specific application should be determined.
Positive_Control: Heart, Placenta, Spleen or Tonsil.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Haltbarkeit
- 24 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- CD274
-
Hintergrund
-
B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1,PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)
Cellular localisation: Cell Surface and Cytoplasmic -
Molekulargewicht
- 37-50kDa
-
Gen-ID
- 29126, 521989
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-